162 related articles for article (PubMed ID: 32160210)
21. Intranasal Delivery of Exendin-4 Confers Neuroprotective Effect Against Cerebral Ischemia in Mice.
Zhang H; Meng J; Zhou S; Liu Y; Qu D; Wang L; Li X; Wang N; Luo X; Ma X
AAPS J; 2016 Mar; 18(2):385-94. PubMed ID: 26689204
[TBL] [Abstract][Full Text] [Related]
22. Intranasal Delivery of Granulocyte Colony-Stimulating Factor Enhances Its Neuroprotective Effects Against Ischemic Brain Injury in Rats.
Sun BL; He MQ; Han XY; Sun JY; Yang MF; Yuan H; Fan CD; Zhang S; Mao LL; Li DW; Zhang ZY; Zheng CB; Yang XY; Li YV; Stetler RA; Chen J; Zhang F
Mol Neurobiol; 2016 Jan; 53(1):320-330. PubMed ID: 25432887
[TBL] [Abstract][Full Text] [Related]
23. Bioluminescent Study of the Distribution of High-Molecular-Weight Protein Fraction of Cellex Daily Preparation in the Brain after Intranasal Administation.
Baklaushev VP; Yusubalieva GM; Burenkov MS; Mel'nikov PA; Bozhko EA; Mentyukov GA; Lavrent'eva LS; Sokolov MA; Chekhonin VP
Bull Exp Biol Med; 2017 Dec; 164(2):285-292. PubMed ID: 29177876
[TBL] [Abstract][Full Text] [Related]
24. Association of riluzole and dantrolene improves significant recovery after acute spinal cord injury in rats.
Martins BC; Torres BBJ; de Oliveira KM; Lavor MS; Osório CM; Fukushima FB; Rosado IR; de Melo EG
Spine J; 2018 Mar; 18(3):532-539. PubMed ID: 29155254
[TBL] [Abstract][Full Text] [Related]
25. Plasma levels of dantrolene following oral administration in malignant hyperthermia-susceptible patients.
Allen GC; Cattran CB; Peterson RG; Lalande M
Anesthesiology; 1988 Dec; 69(6):900-4. PubMed ID: 3057938
[TBL] [Abstract][Full Text] [Related]
26. Neuroprotective effects of early vs. late administration of dantrolene in experimental status epilepticus.
Niebauer M; Gruenthal M
Neuropharmacology; 1999 Sep; 38(9):1343-8. PubMed ID: 10471088
[TBL] [Abstract][Full Text] [Related]
27. Intranasal delivery of erythropoietin plus insulin-like growth factor-I for acute neuroprotection in stroke. Laboratory investigation.
Fletcher L; Kohli S; Sprague SM; Scranton RA; Lipton SA; Parra A; Jimenez DF; Digicaylioglu M
J Neurosurg; 2009 Jul; 111(1):164-70. PubMed ID: 19284235
[TBL] [Abstract][Full Text] [Related]
28. Intranasal haloperidol-loaded miniemulsions for brain targeting: Evaluation of locomotor suppression and in-vivo biodistribution.
El-Setouhy DA; Ibrahim AB; Amin MM; Khowessah OM; Elzanfaly ES
Eur J Pharm Sci; 2016 Sep; 92():244-54. PubMed ID: 27154259
[TBL] [Abstract][Full Text] [Related]
29. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting.
Wang X; Chi N; Tang X
Eur J Pharm Biopharm; 2008 Nov; 70(3):735-40. PubMed ID: 18684400
[TBL] [Abstract][Full Text] [Related]
30. Effect of oral administration of dantrolene sodium on serum creatine kinase activity after exercise in horses with recurrent exertional rhabdomyolysis.
McKenzie EC; Valberg SJ; Godden SM; Finno CJ; Murphy MJ
Am J Vet Res; 2004 Jan; 65(1):74-9. PubMed ID: 14719706
[TBL] [Abstract][Full Text] [Related]
31. Intranasal administration of progesterone: A potential efficient route of delivery for cerebroprotection after acute brain injuries.
Guennoun R; Fréchou M; Gaignard P; Liere P; Slama A; Schumacher M; Denier C; Mattern C
Neuropharmacology; 2019 Feb; 145(Pt B):283-291. PubMed ID: 29885423
[TBL] [Abstract][Full Text] [Related]
32. Nanoemulsions for Intranasal Delivery of Riluzole to Improve Brain Bioavailability: Formulation Development and Pharmacokinetic Studies.
Parikh RH; Patel RJ
Curr Drug Deliv; 2016; 13(7):1130-1143. PubMed ID: 26638977
[TBL] [Abstract][Full Text] [Related]
33. Intranasal administration of brain-targeted HP-β-CD/chitosan nanoparticles for delivery of scutellarin, a compound with protective effect in cerebral ischaemia.
Liu S; Ho PC
J Pharm Pharmacol; 2017 Nov; 69(11):1495-1501. PubMed ID: 28809432
[TBL] [Abstract][Full Text] [Related]
34. Clinical pharmacokinetics of drugs for Alzheimer's disease.
Parnetti L
Clin Pharmacokinet; 1995 Aug; 29(2):110-29. PubMed ID: 7586900
[TBL] [Abstract][Full Text] [Related]
35. The effects of dantrolene on hypoxic-ischemic injury in the neonatal rat brain.
Gwak M; Park P; Kim K; Lim K; Jeong S; Baek C; Lee J
Anesth Analg; 2008 Jan; 106(1):227-33, table of contents. PubMed ID: 18165582
[TBL] [Abstract][Full Text] [Related]
36. Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat Alzheimer's disease.
Zhang C; Chen J; Feng C; Shao X; Liu Q; Zhang Q; Pang Z; Jiang X
Int J Pharm; 2014 Jan; 461(1-2):192-202. PubMed ID: 24300213
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of nose-to-brain delivery of basic fibroblast growth factor for improving rat memory impairments induced by co-injection of β-amyloid and ibotenic acid into the bilateral hippocampus.
Feng C; Zhang C; Shao X; Liu Q; Qian Y; Feng L; Chen J; Zha Y; Zhang Q; Jiang X
Int J Pharm; 2012 Feb; 423(2):226-34. PubMed ID: 22193058
[TBL] [Abstract][Full Text] [Related]
38. Intranasal therapeutic strategies for management of Alzheimer's disease.
Sood S; Jain K; Gowthamarajan K
J Drug Target; 2014 May; 22(4):279-94. PubMed ID: 24404923
[TBL] [Abstract][Full Text] [Related]
39. Electrophysiological effects of intravenous dantrolene on canine heart.
Roewer N; Kuck KH; Kochs E; Schulte am Esch J
Eur J Anaesthesiol; 1987 Sep; 4(5):357-67. PubMed ID: 3428281
[TBL] [Abstract][Full Text] [Related]
40. [Characteristics of pyrrolidone pharmacokinetics in rats].
Sariev AK; Lun'shina EV; Zherdev VP
Eksp Klin Farmakol; 2003; 66(6):50-2. PubMed ID: 14743713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
